Stem Cells, Vol 13, 512-516, Copyright © 1995 by AlphaMed Press

ORIGINAL ARTICLES

Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy

AW Roberts, E DeLuca, CG Begley, R Basser, AP Grigg and D Metcalf
Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.

The elevated white cell counts (WCC) and myeloid progenitor cell levels in the blood induced by granulocyte colony-stimulating factor (G-CSF) treatment were studied in three settings: cancer patients previously treated with chemo/radiotherapy (n = 13), untreated cancer patients (n = 5) and normal volunteers (n = 9). The inter-individual variations in progenitor cell mobilization responses to G-CSF and the impact of previous chemo/radiotherapy were investigated. The absolute levels of circulating progenitor cells, but not total white cells, were reduced significantly in the pretreated cancer patients (median 961, range 289- 3355 per ml blood) as compared to untreated cancer patients (median 9891, range 2219-16625 per ml blood). In each setting, wide ranges of circulating progenitor cell numbers were observed, and the variation in progenitor cell numbers was considerably greater than observed for the WCC. However, progenitor cell numbers in normal volunteers (942-25296 per ml blood) demonstrated as much variance as observed in pretreated cancer patients. This broad physiological variation in progenitor cell levels induced by G-CSF needs to be considered when designing strategies for allogeneic peripheral blood stem cell transplantation.

This article has been cited by other articles:

				S. Vasu, S. F. Leitman, J. F. Tisdale, M. M. Hsieh, R. W. Childs, A. J. Barrett, D. H. Fowler, M. R. Bishop, E. M. Kang, H. L. Malech, et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population Blood, September 1, 2008; 112(5): 2092 - 2100. [Abstract] [Full Text] [PDF]

				M. Abraham, K. Biyder, M. Begin, H. Wald, I. D. Weiss, E. Galun, A. Nagler, and A. Peled Enhanced Unique Pattern of Hematopoietic Cell Mobilization Induced by the CXCR4 Antagonist 4F-Benzoyl-TN14003 Stem Cells, September 1, 2007; 25(9): 2158 - 2166. [Abstract] [Full Text] [PDF]

				H. E. Broxmeyer, C. M. Orschell, D. W. Clapp, G. Hangoc, S. Cooper, P. A. Plett, W. C. Liles, X. Li, B. Graham-Evans, T. B. Campbell, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist J. Exp. Med., April 18, 2005; 201(8): 1307 - 1318. [Abstract] [Full Text] [PDF]

				J. L. Abkowitz, A. E. Robinson, S. Kale, M. W. Long, and J. Chen Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure Blood, August 15, 2003; 102(4): 1249 - 1253. [Abstract] [Full Text] [PDF]

				R. Kronenwett, S. Martin, and R. Haas The Role of Cytokines and Adhesion Molecules for Mobilization of Peripheral Blood Stem Cells Stem Cells, September 1, 2000; 18(5): 320 - 330. [Abstract] [Full Text]

				G. de Haan, S. J. Szilvassy, T. E. Meyerrose, B. Dontje, B. Grimes, and G. Van Zant Distinct functional properties of highly purified hematopoietic stem cells from mouse strains differing in stem cell numbers Blood, August 15, 2000; 96(4): 1374 - 1379. [Abstract] [Full Text] [PDF]

				C.G. Begley, R. Basser, R. Mansfield, B. Thomson, W.R.L. Parker, J. Layton, B. To, J. Cebon, W.P. Sheridan, R.M. Fox, et al. Enhanced Levels and Enhanced Clonogenic Capacity of Blood Progenitor Cells Following Administration of Stem Cell Factor Plus Granulocyte Colony-Stimulating Factor to Humans Blood, November 1, 1997; 90(9): 3378 - 3389. [Abstract] [Full Text] [PDF]

				R. L. Basser, J. E.J. Rasko, K. Clarke, J. Cebon, M. D. Green, A. P. Grigg, J. Zalcberg, B. Cohen, J. O'Byrne, D. M. Menchaca, et al. Randomized, Blinded, Placebo-Controlled Phase I Trial of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor With Filgrastim After Dose-Intensive Chemotherapy in Patients With Advanced Cancer Blood, May 1, 1997; 89(9): 3118 - 3128. [Abstract] [Full Text] [PDF]

				J. E.J. Rasko, E. O'Flaherty, and C. G. Begley Mpl Ligand (MGDF) Alone and in Combination with Stem Cell Factor (SCF) Promotes Proliferation and Survival of Human Megakaryocyte, Erythroid and Granulocyte/Macrophage Progenitors Stem Cells, January 1, 1997; 15(1): 33 - 42. [Abstract] [Full Text]